MARKET

REGN

REGN

Regeneron Pharmaceuticals
NASDAQ
904.35
+1.45
+0.16%
After Hours: 902.09 -2.26 -0.25% 19:58 11/06 EST
OPEN
887.22
PREV CLOSE
902.90
HIGH
911.64
LOW
887.04
VOLUME
1.12M
TURNOVER
--
52 WEEK HIGH
991.73
52 WEEK LOW
590.83
MARKET CAP
93.55B
P/E (TTM)
19.97
1D
5D
1M
3M
1Y
5Y
1D
Democratic lawmakers seen probing Trump drug pricing deals come January
Seeking Alpha · 1d ago
Regeneron Updates Key PNH Combination Study: What REGN Investors Should Know
TipRanks · 1d ago
Regeneron (REGN) Stock May Trade At A Discount Following Strong Q3 Earnings
Simply Wall St · 2d ago
Regeneron Advances ALN-CIDEB Into Phase 3 Liver Disease Study
TipRanks · 2d ago
BofA adds TMUS, REGN to Value 10 list, leaves Growth 10 untouched
Seeking Alpha · 3d ago
Why Regeneron (REGN) Might be Well Poised for a Surge
NASDAQ · 3d ago
REGN vs. ILMN: Which Stock Is the Better Value Option?
NASDAQ · 3d ago
How Investors May Respond To Regeneron Pharmaceuticals (REGN) Earnings Beat
Simply Wall St · 3d ago
More
About REGN
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Lynozyfic, and others.

Webull offers Regeneron Pharmaceuticals Inc stock information, including NASDAQ: REGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REGN stock methods without spending real money on the virtual paper trading platform.